Molecular Human Reproduction, Vol. 5, No. 7, 656-661,
July 1999
© 1999 European Society of Human Reproduction and Embryology
Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle
1 Department of Obstetrics and Gynecology, Faculty of Medicine, Osaka University, 22 Yamada-oka, Suita City, Osaka 565-0871, 2 Department of Obstetrics and Gynecology, Osaka Police Hospital, 1031 Kitayama-cho, Tennouji-ku, Osaka 543-8502, and 3 Department of Gynecology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 133 Nakamichi, Higashinari-ku, Osaka 537-0025, Japan.
Secretory leukocyte protease inhibitor (SLPI) is a potent inhibitor of human leukocyte elastase. SLPI transcripts in the cervical tissue were detected during the menstrual cycle by reverse transcriptionpolymerase chain reaction (RTPCR). Western blot analysis revealed that the intensity of SLPI protein in cervical tissue in the ovulatory phase was stronger than in other phases. Immunohistochemistry using an anti-SLPI polyclonal antibody revealed positive staining in the epithelial cells of the endocervix. Western blot analysis also revealed that SLPI protein was present in the cervical mucus. Again the intensity of SLPI protein in the ovulatory phase was stronger than that in the follicular phase. The SLPI concentrations and SLPI/elastase ratios in the cervical mucus of women in the ovulatory phase were significantly higher than in the follicular and luteal phases. The SLPI and elastase concentrations in the cervical mucus were positively correlated. No significant difference was found in the SLPI serum concentrations of women during the menstrual cycle. These results suggest that production of SLPI from cervical epithelial cells during the ovulatory phase may be important for protection from the effects of elastase.
cervical mucus/ovulation/secretory leukocyte protease inhibitor (SLPI)
4 To whom correspondence should be addressed at: Department of Obstetrics and Gynecology, Faculty of Medicine, Osaka University, 22 Yamada-oka, Suita City, Osaka 565-0871, Japan. e-mail: shimoya{at}gyne.med.osaka-u.ac.jp
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. E. King, N. Wheelhouse, S. Cameron, S. E. McDonald, K.-F. Lee, G. Entrican, H. O.D. Critchley, and A. W. Horne Expression of secretory leukocyte protease inhibitor and elafin in human fallopian tube and in an in-vitro model of Chlamydia trachomatis infection Hum. Reprod., March 1, 2009; 24(3): 679 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Andersson, D. Minjarez, N. P. Yost, and R. A. Word Estrogen and Progesterone Metabolism in the Cervix during Pregnancy and Parturition J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2366 - 2374. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W Horne, S. J Stock, and A. E King Innate immunity and disorders of the female reproductive tract Reproduction, June 1, 2008; 135(6): 739 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Klein, K. R. Jonscher, M. J. Heerwagen, R. S. Gibbs, and J. L. McManaman Shotgun Proteomic Analysis of Vaginal Fluid From Women in Late Pregnancy Reproductive Sciences, March 1, 2008; 15(3): 263 - 273. [Abstract] [PDF] |
||||
![]() |
L. Ming, P. Xiaoling, L. Yan, W. Lili, W. Qi, Y. Xiyong, W. Boyao, and H. Ning Purification of antimicrobial factors from human cervical mucus Hum. Reprod., July 1, 2007; 22(7): 1810 - 1815. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Andersch-Bjorkman, K. A. Thomsson, J. M. Holmen Larsson, E. Ekerhovd, and G. C. Hansson Large Scale Identification of Proteins, Mucins, and Their O-Glycosylation in the Endocervical Mucus during the Menstrual Cycle Mol. Cell. Proteomics, April 1, 2007; 6(4): 708 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ota, K. Shimoya, Q. Zhang, A. Moriyama, R. Chin, K. Tenma, T. Kimura, M. Koyama, C. Azuma, and Y. Murata The expression of secretory leukocyte protease inhibitor (SLPI) in the Fallopian tube: SLPI protects the acrosome reaction of sperm from inhibitory effects of elastase Hum. Reprod., October 1, 2002; 17(10): 2517 - 2522. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, K. Shimoya, A. Moriyama, K. Yamanaka, A. Nakajima, T. Nobunaga, M. Koyama, C. Azuma, and Y. Murata Production of secretory leukocyte protease inhibitor by human amniotic membranes and regulation of its concentration in amniotic fluid Mol. Hum. Reprod., June 1, 2001; 7(6): 573 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shimoya, A. Moriyama, I. Ogata, T. Nobunaga, M. Koyama, C. Azuma, and Y. Murata Increased concentrations of secretory leukocyte protease inhibitor in peritoneal fluid of women with endometriosis Mol. Hum. Reprod., September 1, 2000; 6(9): 829 - 834. [Abstract] [Full Text] [PDF] |
||||





